Clinical trial

Sacubitril/Allisartan for Hypertensive Patients With Overweight or Obesity

NCT07241338

Study summary

ClinicalTrials.gov

Sacubitril/Allisartan for Hypertensive Patients With Overweight or Obesity

Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention sacubitril/allisartan Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Amlodipine Normalized identity: amlodipine View linked drug · Find medicine records · Find other trials using this name

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2025-11-01

PhasePHASE4

Conditions

Hypertensionunresolved

Interventions

sacubitril/allisartanDRUG

AmlodipineDRUG · verified · RxNorm: amlodipine

Sponsors & collaborators

Jing Liulead sponsor

Mapped research locations

BeijingChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07241338 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.